
Senior Scientist III @GensaicBio | Own opinions
Cambridge, MA
Joined May 2018
- Tweets513
- Following333
- Followers126
- Likes1.1K
Sungmin Baek retweeted
Interested in single cell and spatial genomics? Check out the agenda for our 10th Single Cell Genomics Day on Friday 6/12.
Speakers: Aviv Regev @anshulkundaje @junyue_cao @xinjin + many more! All talks are free and live-streamed at satijalab.org/scgd
Sungmin Baek retweeted
Today in @ScienceMagazine, we report a new DNA editing technology to seamlessly write massive changes into the right place in the human genome.
The reason gene editing hasn't transformed human health is that current gene editing technologies like CRISPR are very limited.
The problem with CRISPR is that it cuts up your DNA, and then hopes that unreliable cellular DNA repair will make the wanted edit. @geochurch famously called it genome vandalism. More precise versions of CRISPR only edit less than 100 bases - often only a single base. Therefore, it's not suited to make large changes safely.
However, most diseases are not the result of mutations in one location. Instead, their causes are spread all across the 3 billion base pairs in the genome.
We found bridge RNAs in bacterial “jumping genes” that allow us to make safe and arbitrary changes (insert, cut out, or flip) to every nucleotide within (up to) a 1 million bp sequence in your DNA.
In the paper, we show that we can correct the disease-causing DNA repeats that cause Friedreich's ataxia (which is a rare neurological disease). The same approach could be applied to Huntington’s and other repeat expansion disorders.
At @arcinstitute, we're working towards a full Turing machine for biology. Evo, our DNA foundation model, helps us design the optimal healthy DNA sequences. And Bridge recombination gives us the ability to seamlessly write these changes into the right place in the genome.
This work was a wonderful collaboration with my @arcinstitute cofounder @SKonermann and led by the indefatigable @ntperry13, alongside our amazing bridge editing team: @BartieLiam @dhruvakatrekar @Gabogonzalez515 @mgdurrant @james_jw_pai @AlisonFanton Juliana Martins Masa Hiraizumi @chiaroscurale @hnisimasu
What if we could universally recombine, insert, delete, or invert any two pieces of DNA?
In back-to-back @Nature papers, we report the discovery of bridge RNAs and 3 atomic structures of the first natural RNA-guided recombinase - a new mechanism for programmable genome design
Sungmin Baek retweeted
"In the last year of my PhD, I knew I was going to start a company, so I started thinking about a name. I worked on it, old-style, on a sheet of paper for maybe an hour a day for a couple of weeks." go.nature.com/3Iv0MEE
Sungmin Baek retweeted
A vast landscape of ‘undruggable’ cancer targets remains beyond the reach of conventional therapeutic agents. Recent advances in artificial intelligence are challenging this paradigm go.nature.com/4fHNMYi
Sungmin Baek retweeted
Finding functional microproteins dlvr.it/TH8Kr9
Sungmin Baek retweeted
📢New human fetal pancreatic organoid model generates all three key cell types of the pancreas. New paper in @CellCellPress by @AmandaARolf , @HansClevers and collaborators. See the article here: sciencedirect.com/science/ar…
Sungmin Baek retweeted
Stronger promoters not only transcribe more RNA but also show higher effective translation rates.
Sungmin Baek retweeted
Environmental and molecular control of tissue-specific ionocyte differentiation in zebrafish
#DevSIDiversity Research Article by @jupeloggia @LabPiotrowski & co @ScienceStowers: journals.biologists.com/dev/…
🎥A Nm ionocyte progenitor dividing & the resulting pair invading a neuromast
Sungmin Baek retweeted
Come and join us! We are looking for a bioinformatician to join the lab. Work with single cell, multiome and spatial data from model systems and human samples! Our focus is lymphatics and blood brain barrier in development, regeneration and cancer.
seek.com.au/job/79558172
Sungmin Baek retweeted
We’re thrilled to announce @FierceBiotech has selected us as a 2024 #Fierce15 #biotech company! This year we have rapidly advanced our ProFoundry™ Platform identifying novel proteins with the possibility to bring new therapeutic options to patients. More: bit.ly/3YwXMgt
Sungmin Baek retweeted
So powerful:
Readers added context they thought people might want to know
Warren Buffett did not tweet or say this and the account alleged to have shared the fake quote has been suspended.
aap.com.au/factcheck/emot…
Sungmin Baek retweeted
Our latest POSTER with @NatRevImmunol explores rationale combinations of #immunecheckpointblockade of #PD1-#PDL1, with other therapies aimed at targeting effector T cells, innate immune + regulatory T cells, the #TME & cancer cells.
Check it out now!
go.nature.com/3WLcCh5
Sungmin Baek retweeted
NEW content online! Enhancing cellular immunotherapies in cancer by engineering selective therapeutic resistance go.nature.com/4d9hpzu
Sungmin Baek retweeted
Large-scale discovery of chromatin dysregulation induced by oncofusions and other protein-coding variants go.nature.com/3Wib3qr
Sungmin Baek retweeted
NEW content online! Cancer organoids 2.0: modelling the complexity of the tumour immune microenvironment dlvr.it/TB0ftH
Sungmin Baek retweeted
On my way to Atlanta for #SDB2024! If you're curious about the role of immune cells during hair cell regeneration in zebrafish, stop by my poster tonight @SocDevBio @ScienceStowers @LabPiotrowski
Sungmin Baek retweeted
Thank you, @NYSE, for celebrating our most recent capital raise! For more on how this raise will fuel the creation and growth of breakthrough companies in human health, sustainability, and artificial intelligence, watch @NoubarAfeyan, Flagship Founder & CEO, as he discusses Flagship’s recent advances including key partnerships, expanding our global footprint, and assembling top talent: bit.ly/4bENCgK
Sungmin Baek retweeted
Bacteria in metastatic sites: Unveiling hidden players in cancer progression dlvr.it/T9Vrt5
Sungmin Baek retweeted
Precise in vivo RNA base editing with a wobble-enhanced circular CLUSTER guide RNA go.nature.com/3zBhiOl
































